• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶在腹腔内感染外科患者中的处置情况。

Disposition of ceftazidime in surgical patients with intra-abdominal infection.

作者信息

Heim-Duthoy K L, Bubrick M P, Cocchetto D M, Matzke G R

机构信息

Drug Evaluation Unit, Hennepin County Medical Center, Minneapolis, Minnesota 55415.

出版信息

Antimicrob Agents Chemother. 1988 Dec;32(12):1845-7. doi: 10.1128/AAC.32.12.1845.

DOI:10.1128/AAC.32.12.1845
PMID:3072925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176030/
Abstract

The disposition of ceftazidime was assessed in 11 surgical patients with suspected intra-abdominal infection. All patients had normal hepatic function, and creatinine clearances ranged from 43 to 186 ml/min. Patients received 2 g of ceftazidime intravenously every 8 h. Trough and peak concentrations in serum were measured on day 2, and trough and postdose concentrations in serum were determined on 10 samples collected during a dosage interval between days 3 and 6 of therapy. Ceftazidime peak and trough concentrations in serum at steady state determined by high-performance liquid chromatography were 257.4 +/- 122.0 (mean +/- standard deviation) and 13.1 +/- 20.6 mg/liter. The serum-concentration-versus-time profile was multiexponential. The elimination half-life, steady-state volume of distribution, and total body clearance were 2.52 +/- 1.39 h, 0.31 +/- 0.12 liter/kg, and 0.11 +/- 0.05 liter/h per kg, respectively. Total predicted body clearance significantly correlated with the measured values (r = 0.868; P = 0.001). The disposition of ceftazidime is dependent on creatinine clearance and is not significantly altered by surgery or acute infectious processes.

摘要

对11例疑似腹腔内感染的外科手术患者的头孢他啶处置情况进行了评估。所有患者肝功能均正常,肌酐清除率范围为43至186 ml/分钟。患者每8小时静脉注射2g头孢他啶。在第2天测量血清中的谷浓度和峰浓度,并在治疗第3天至第6天的给药间隔期间采集的10份样本中测定血清中的谷浓度和给药后浓度。通过高效液相色谱法测定的稳态时血清中头孢他啶的峰浓度和谷浓度分别为257.4±122.0(平均值±标准差)和13.1±20.6mg/升。血清浓度-时间曲线为多指数曲线。消除半衰期、稳态分布容积和全身清除率分别为2.52±1.39小时、0.31±0.12升/千克和0.11±0.05升/小时/千克。预测的总全身清除率与测量值显著相关(r = 0.868;P = 0.001)。头孢他啶的处置情况取决于肌酐清除率,不受手术或急性感染过程的显著影响。

相似文献

1
Disposition of ceftazidime in surgical patients with intra-abdominal infection.头孢他啶在腹腔内感染外科患者中的处置情况。
Antimicrob Agents Chemother. 1988 Dec;32(12):1845-7. doi: 10.1128/AAC.32.12.1845.
2
Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.健康志愿者连续和间歇输注期间头孢他啶在血清和水疱抽吸液中的药代动力学。
Antimicrob Agents Chemother. 1990 Dec;34(12):2307-11. doi: 10.1128/AAC.34.12.2307.
3
Pharmacokinetics of cefonicid in patients with skin and skin structure infections.头孢尼西在皮肤及皮肤结构感染患者中的药代动力学
Antimicrob Agents Chemother. 1988 Apr;32(4):485-7. doi: 10.1128/AAC.32.4.485.
4
Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections.在对重症腹腔内感染患者进行持续给药与间歇给药期间,头孢他啶在血清和腹腔渗出液中的药代动力学。
J Antimicrob Chemother. 2002 Jan;49(1):121-8. doi: 10.1093/jac/49.1.121.
5
The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.头孢他啶在肾功能受损且同时接受速尿治疗患者中的药代动力学。
Eur J Clin Pharmacol. 1988;35(3):273-9. doi: 10.1007/BF00558265.
6
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.SCE - 2787与头孢他啶的比较药代动力学及血清杀菌活性
Antimicrob Agents Chemother. 1993 Sep;37(9):1835-41. doi: 10.1128/AAC.37.9.1835.
7
Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.接受持续静脉-静脉血液透析滤过的危重症患者中头孢他啶的持续输注:药代动力学评估及剂量推荐
Crit Care. 2006 Feb;10(1):R26. doi: 10.1186/cc3993.
8
Pharmacokinetics of cefepime in patients with respiratory tract infections.头孢吡肟在呼吸道感染患者中的药代动力学。
Antimicrob Agents Chemother. 1990 Oct;34(10):1885-8. doi: 10.1128/AAC.34.10.1885.
9
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.行体外脑室引流术患者的脑脊液头孢他啶动力学
Antimicrob Agents Chemother. 1996 Mar;40(3):763-6. doi: 10.1128/AAC.40.3.763.
10
Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration.头孢他啶间歇性给药对烧伤患者的影响:肾小球滤过的作用
Int J Clin Pharmacol Ther. 2007 Mar;45(3):133-42. doi: 10.5414/cpp45133.

引用本文的文献

1
Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.头孢洛扎/他唑巴坦用于医院获得性肺炎患者3期研究的药代动力学/药效学推导剂量合理性
J Clin Pharmacol. 2016 Jan;56(1):56-66. doi: 10.1002/jcph.566. Epub 2015 Aug 25.
2
Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.老年患者中五种广谱头孢菌素的血清杀菌活性和药代动力学的交叉评估。
Antimicrob Agents Chemother. 1990 Jun;34(6):1007-13. doi: 10.1128/AAC.34.6.1007.
3
Pharmacokinetics of cefepime in patients with respiratory tract infections.头孢吡肟在呼吸道感染患者中的药代动力学。
Antimicrob Agents Chemother. 1990 Oct;34(10):1885-8. doi: 10.1128/AAC.34.10.1885.

本文引用的文献

1
Ceftazidime: pharmacokinetics in patients and effects on the renal function.
J Antimicrob Chemother. 1982 Sep;10(3):199-206. doi: 10.1093/jac/10.3.199.
2
Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.单环β-内酰胺类药物氨曲南(SQ 26,776)在健康受试者中的多剂量药代动力学。
Antimicrob Agents Chemother. 1983 Jan;23(1):125-32. doi: 10.1128/AAC.23.1.125.
3
Is renal function the only determinant in the elimination of ceftazidime?肾功能是头孢他啶消除的唯一决定因素吗?
Rev Infect Dis. 1984 Sep-Oct;6(5):732-5. doi: 10.1093/clinids/6.5.732.
4
Pharmacokinetics of ceftazidime in normal and uremic subjects.头孢他啶在正常人和尿毒症患者体内的药代动力学。
Antimicrob Agents Chemother. 1984 May;25(5):638-42. doi: 10.1128/AAC.25.5.638.
5
Pharmacokinetics of ceftazidime in patients with renal insufficiency.头孢他啶在肾功能不全患者中的药代动力学。
Antimicrob Agents Chemother. 1984 Feb;25(2):201-4. doi: 10.1128/AAC.25.2.201.
6
Pharmacokinetics of ceftazidime in normal and impaired renal function.
Arzneimittelforschung. 1984;34(1):72-6.
7
High-pressure liquid chromatographic analysis of ceftazidime in serum and urine.血清和尿液中头孢他啶的高效液相色谱分析
Antimicrob Agents Chemother. 1983 Nov;24(5):720-4. doi: 10.1128/AAC.24.5.720.
8
Pharmacokinetics of aztreonam in patients with gram-negative infections.氨曲南在革兰氏阴性菌感染患者中的药代动力学。
Antimicrob Agents Chemother. 1985 Jan;27(1):16-20. doi: 10.1128/AAC.27.1.16.
9
Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime.头孢他啶的抗菌活性、药代动力学、治疗指征及不良反应。
Pharmacotherapy. 1985 Sep-Oct;5(5):254-67. doi: 10.1002/j.1875-9114.1985.tb03424.x.
10
Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
Am J Med. 1987 Apr 27;82(4A):124-9.